China Pharma enters into up to $600,000 at-the-market equity offering with institutional investor

CHINA PHARMA HOLDINGS, INC.

SPA signed Dec 12, 2024 for up to $600K of common stock at market price, floor $0.15.
Commitment period Dec 12 – Dec 31, 2024; investor has sole discretion to purchase.
Pricing: lower of prior day close or 5-day avg; repricing if delivery delayed; MFN clause for 30 days.
Investor may return shares within one business day for any reason; no minimum offering amount.
Shares issued under existing S-3 shelf (File 333-276481); proceeds not determinable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.